cepharanthine has been researched along with Lymphoma, Primary Effusion in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hiyoshi, M; Katano, H; Ohsugi, T; Okada, S; Suzu, S; Takahashi-Makise, N; Umezawa, K | 1 |
1 other study(ies) available for cepharanthine and Lymphoma, Primary Effusion
Article | Year |
---|---|
Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzylisoquinolines; Blotting, Western; Caspase Inhibitors; Caspases; Cell Cycle; Cell Proliferation; Electrophoretic Mobility Shift Assay; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunoenzyme Techniques; In Vitro Techniques; Lymphoma, Primary Effusion; Male; Mice; Mice, Inbred NOD; Mice, SCID; NF-kappa B; Polymerase Chain Reaction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |